Article
Lake Street Maintains Buy on Treace Medical Concepts, Lowers Price Target to $7
Lake Street analyst Ben Haynor maintains Treace Medical Concepts (NASDAQ:TMCI) with a Buy and lowers the price target from $7.5 to $7.
Comments
- No comments yet. Be the first to comment!